Literature DB >> 27827809

IL-1 signaling is critical for expansion but not generation of autoreactive GM-CSF+ Th17 cells.

Ilgiz A Mufazalov1, Carsten Schelmbauer2, Tommy Regen2, Janina Kuschmann2, Florian Wanke2, Laureen A Gabriel2, Judith Hauptmann2, Werner Müller3, Emmanuel Pinteaux3, Florian C Kurschus2, Ari Waisman1.   

Abstract

Interleukin-1 (IL-1) is implicated in numerous pathologies, including multiple sclerosis and its animal model experimental autoimmune encephalomyelitis (EAE). However, the exact mechanism by which IL-1 is involved in the generation of pathogenic T cells and in disease development remains largely unknown. We found that following EAE induction, pertussis toxin administration leads to IL-1 receptor type 1 (IL-1R1)-dependent IL-1β expression by myeloid cells in the draining lymph nodes. This myeloid-derived IL-1β did not vitally contribute to the generation and plasticity of Th17 cells, but rather promoted the expansion of a GM-CSF+ Th17 cell subset, thereby enhancing its encephalitogenic potential. Lack of expansion of GM-CSF-producing Th17 cells led to ameliorated disease in mice deficient for IL-1R1 specifically in T cells. Importantly, pathogenicity of IL-1R1-deficient T cells was fully restored by IL-23 polarization and expansion in vitro Therefore, our data demonstrate that IL-1 functions as a mitogenic mediator of encephalitogenic Th17 cells rather than qualitative inducer of their generation.
© 2016 The Authors.

Entities:  

Keywords:  EAE; GM‐CSF; IL‐1; Th17; autoimmunity

Mesh:

Substances:

Year:  2016        PMID: 27827809      PMCID: PMC5210124          DOI: 10.15252/embj.201694615

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  68 in total

1.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

Authors:  Laura Codarri; Gabor Gyülvészi; Vinko Tosevski; Lysann Hesske; Adriano Fontana; Laurent Magnenat; Tobias Suter; Burkhard Becher
Journal:  Nat Immunol       Date:  2011-04-24       Impact factor: 25.606

Review 2.  Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF.

Authors:  Alexandre Paré; Benoit Mailhot; Sébastien A Lévesque; Steve Lacroix
Journal:  Brain Behav Immun       Date:  2016-07-16       Impact factor: 7.217

3.  Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.

Authors:  Marco Frentsch; Olga Arbach; Dennis Kirchhoff; Beate Moewes; Margitta Worm; Martin Rothe; Alexander Scheffold; Andreas Thiel
Journal:  Nat Med       Date:  2005-09-25       Impact factor: 53.440

Review 4.  Statistical analysis of data from studies on experimental autoimmune encephalomyelitis.

Authors:  Kandace K Fleming; James A Bovaird; Michael C Mosier; Mitchell R Emerson; Steven M LeVine; Janet G Marquis
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

5.  GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis.

Authors:  Eugene D Ponomarev; Leah P Shriver; Katarzyna Maresz; Joao Pedras-Vasconcelos; Daniela Verthelyi; Bonnie N Dittel
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

6.  Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.

Authors:  Felix J Hartmann; Mohsen Khademi; Jehan Aram; Sandra Ammann; Ingrid Kockum; Cris Constantinescu; Bruno Gran; Fredrik Piehl; Tomas Olsson; Laura Codarri; Burkhard Becher
Journal:  Nat Commun       Date:  2014-10-03       Impact factor: 14.919

7.  Regulating human Th17 cells via differential expression of IL-1 receptor.

Authors:  Won-Woo Lee; Seong Wook Kang; Jihoon Choi; Seung-Hyun Lee; Kamini Shah; Elizabeth E Eynon; Richard A Flavell; Insoo Kang
Journal:  Blood       Date:  2009-11-12       Impact factor: 22.113

8.  Cellular mechanisms of IL-17-induced blood-brain barrier disruption.

Authors:  Jula Huppert; Dorothea Closhen; Andrew Croxford; Robin White; Paulina Kulig; Eweline Pietrowski; Ingo Bechmann; Burkhard Becher; Heiko J Luhmann; Ari Waisman; Christoph R W Kuhlmann
Journal:  FASEB J       Date:  2009-11-25       Impact factor: 5.191

9.  IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.

Authors:  H P Eugster; K Frei; M Kopf; H Lassmann; A Fontana
Journal:  Eur J Immunol       Date:  1998-07       Impact factor: 5.532

10.  A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.

Authors:  I Mendel; N Kerlero de Rosbo; A Ben-Nun
Journal:  Eur J Immunol       Date:  1995-07       Impact factor: 5.532

View more
  23 in total

1.  Expression of IL-17F is associated with non-pathogenic Th17 cells.

Authors:  Florian Wanke; Yilang Tang; Konrad Gronke; Sabrina Klebow; Sonja Moos; Judith Hauptmann; Arthi Shanmugavadivu; Tommy Regen; Ilgiz A Mufazalov; Lauren A Gabriel; Sonja Reißig; Andreas Diefenbach; Florian C Kurschus; Ari Waisman
Journal:  J Mol Med (Berl)       Date:  2018-06-29       Impact factor: 4.599

Review 2.  Metabolic regulation of inflammasomes in inflammation.

Authors:  Qiuli Yang; Ruichen Liu; Qing Yu; Yujing Bi; Guangwei Liu
Journal:  Immunology       Date:  2019-04-08       Impact factor: 7.397

Review 3.  Transcription Factor Bhlhe40 in Immunity and Autoimmunity.

Authors:  Melissa E Cook; Nicholas N Jarjour; Chih-Chung Lin; Brian T Edelson
Journal:  Trends Immunol       Date:  2020-10-07       Impact factor: 16.687

4.  Different interleukin-17-secreting Toll-like receptor+ T-cell subsets are associated with disease activity in multiple sclerosis.

Authors:  Thais B Ferreira; Joana Hygino; Ana Cristina Wing; Taissa M Kasahara; Priscila M Sacramento; Solange Camargo; Fernanda Rueda; Soniza V Alves-Leon; Regina Alvarenga; Claudia Cristina Vasconcelos; Anshu Agrawal; Sudhir Gupta; Cleonice A M Bento
Journal:  Immunology       Date:  2017-12-26       Impact factor: 7.397

5.  IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells.

Authors:  Alexandre Paré; Benoit Mailhot; Sébastien A Lévesque; Camille Juzwik; Prenitha Mercy Ignatius Arokia Doss; Marc-André Lécuyer; Alexandre Prat; Manu Rangachari; Alyson Fournier; Steve Lacroix
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-22       Impact factor: 11.205

Review 6.  The IL-1β phenomena in neuroinflammatory diseases.

Authors:  Andrew S Mendiola; Astrid E Cardona
Journal:  J Neural Transm (Vienna)       Date:  2017-05-22       Impact factor: 3.575

Review 7.  The role of transforming growth factor β in T helper 17 differentiation.

Authors:  Song Zhang
Journal:  Immunology       Date:  2018-05-08       Impact factor: 7.397

Review 8.  New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Chih-Chung Lin; Brian T Edelson
Journal:  J Immunol       Date:  2017-06-15       Impact factor: 5.422

Review 9.  Regulation of IL-1 signaling by the decoy receptor IL-1R2.

Authors:  Thomas Schlüter; Carsten Schelmbauer; Khalad Karram; Ilgiz A Mufazalov
Journal:  J Mol Med (Berl)       Date:  2018-08-15       Impact factor: 4.599

10.  IL-1 signaling is critical for expansion but not generation of autoreactive GM-CSF+ Th17 cells.

Authors:  Ilgiz A Mufazalov; Carsten Schelmbauer; Tommy Regen; Janina Kuschmann; Florian Wanke; Laureen A Gabriel; Judith Hauptmann; Werner Müller; Emmanuel Pinteaux; Florian C Kurschus; Ari Waisman
Journal:  EMBO J       Date:  2016-11-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.